Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Shareholder Alert: Ademi LLP investigates whether Apellis Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders
-
Investeringsforeningen Nykredit Invest Balance - ophævelse af suspension
-
Investeringsforeningen Multi Manager Invest - ophævelse af suspension
-
Shareholder Alert: Ademi LLP investigates whether McCormick & Company, Incorporated’s Transaction with Unilever is Fair to Public Shareholders
-
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders
-
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
-
NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia
-
UgoWork brings AI-powered fleet intelligence and MHE performance insights to MODEX 2026
-
CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
-
Creative Realities, Inc. Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call Information
-
Everbright Health Announces AI-Enabled Platform to Unlock Access to Advanced Mental Health Interventions
-
International Association of Fire Chiefs Launches National Volunteer Firefighter Recruitment Campaign
-
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference
-
Bread Financial Schedules First Quarter 2026 Earnings Conference Call for Apr. 23
-
Shareholder Alert: Ademi LLP investigates whether Kezar Life Sciences, Inc. is obtaining a Fair Price for Public Shareholders
-
Shareholder Alert: Ademi LLP investigates whether Olaplex Holdings Inc. is obtaining a Fair Price for Public Shareholders
-
Shareholder Alert: Ademi LLP investigates whether Equitable Holdings Inc. is obtaining a Fair Price for Public Shareholders
-
Neuroscale AI Joins HPE Unleash AI Partner Program to Bring Signal-Based, Agentic Recruiting to Enterprise AI Deployments
-
Akamai Teams with Arrow Electronics to Power and Protect Digital Experiences at Scale
-
Pluristyx Extends Patent Portfolio in Universal Cell Therapy with New U.S. Patent for iACT Stealth™ Technology
-
Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health
-
Highlander Silver Provides Update; Drilling Commences at Corani Silver Project
-
Vantage Hemp Co. Engages ACOs and GPOs to Advance Participation in CMS CBD Pilot Program
-
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
-
Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials
-
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
-
Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts
-
Soleo Health Relocates Denver Specialty Pharmacy to Support Continued Growth
-
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
-
Autolus Therapeutics to Participate in Upcoming Investor Conferences
-
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
-
Plug Participating in RBC Non-Deal Roadshow in Canada
-
Baker Hughes Secures Strategic Gas Technology Order Supporting Argentina’s Gas Infrastructure
-
Schouw & Co. share buy-back programme, week 14 2026
-
Signify share repurchase periodic update
-
TRiCares Receives FDA Approval for TRICURE US IDE Pivotal Trial with the Topaz Tricuspid Valve Replacement System
-
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly
-
Shareholder Alert: Ademi LLP investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders
-
Golar LNG Limited – Q1 2026 results presentation
-
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology
-
Novo Nordisk A/S – Share repurchase programme
-
Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit
-
BOSS Zhipin Continues Share Repurchases, with Total Repurchases Amounting to Nearly RMB700 Million in 2026
-
Freight Technologies Launches DODA Smart, an AI-Powered Customs Compliance Platform for Mexican Trade Operators
-
Kraken Robotics Demonstrates KATFISH Autonomous Launch and Recovery from SEFINE USV
-
Arastelle Joins Red Cat Futures Initiative to Expand Persistent ISR and Tactical Communications Capabilities
-
Equativ helps advertisers reclaim viewer attention with Creative Enhancements
-
Resolutions of the Annual General Meeting of shareholders of EfTEN Real Estate Fund AS on 7 April 2026
-
Delisting of Exchange Traded Products
-
Invitation to HMS Networks’ first quarter conference call 2026

